Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023
(per 100,000 transfusions)
Characteristic
Number of adverse effects in recipients
-
-
-
-
-
-
-
-
-
-
The chart is not accessible to screen readers. Please switch to the table view to access the data.
You need a ÌÇÐÄÆƽâ°æ Account for unlimited access
This chart shows the evolution of the number of adverse effects with probable or certain causality* among blood transfusion recipients (AER) per 100,000 transfusions in France from 2019 to 2023. In 2023, ** blood transfusions per 100,000 had adverse effects in recipients with probable or certain causality.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EFS. (May 6, 2024). Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023 (per 100,000 transfusions) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 04, 2026, from /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/
EFS. "Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023 (per 100,000 transfusions)." Chart. May 6, 2024. ÌÇÐÄÆƽâ°æ. Accessed August 04, 2026. /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/
EFS. (2024). Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023 (per 100,000 transfusions). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 04, 2026. /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/
EFS. "Evolution of The Number of Adverse Effects with Probable or Certain Imputability among Blood Transfusion Recipients (Aer) in France from 2019 to 2023 (per 100,000 Transfusions)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 6 May 2024, /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/
EFS, Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023 (per 100,000 transfusions) ÌÇÐÄÆƽâ°æ, /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/ (last visited August 04, 2026)
Evolution of the number of adverse effects with probable or certain imputability among blood transfusion recipients (AER) in France from 2019 to 2023 (per 100,000 transfusions) [Graph], EFS, May 6, 2024. [Online]. Available: /statistics/1628643/eir-declaration-rate-france-family-labile-blood-products/
